PatternsRadar
Sign in

IOLCPIOL Chemicals and Pharmaceuticals Limited

NSE
Full chart
214.90INR+9.19 (+4.47%)Close · 6 Oct 2026
10 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹6,308 CrMarket cap
37.5P/E (TTM)
38.9%Delivery

Filings & corporate actions

63 results filed
CSV
Next results · Q2 FY27
Expected 8 Nov 2026 – 15 Nov 2026
Estimate: filed 39–46 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 17 Feb 2026
2026
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone-1.9%NSE
  • 4 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
  • 20 MayresultsResults · Q4 FY26 · consolidated and standalone+1.4%NSE
  • 15 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
  • 17 FebdividendDividend · ₹1.00 per share-0.3%
  • 11 FebresultsResults · Q3 FY26 · consolidated and standalone-0.9%NSE
  • 9 JanshareholdingShareholding · 31 Dec 2025-1.9%NSE

Reaction to results · all yearsrose on day 0 in 20 of 64 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2710 Aug 2026-1.9%-3.9%+26.9%5.1×
Q4 FY2620 May 2026+1.4%+7.9%+8.9%4.0×
Q3 FY2611 Feb 2026-0.9%-1.4%-8.6%1.6×
Q2 FY2611 Nov 2025+10.9%+4.0%-7.5%23.0×
Q1 FY267 Aug 2025+3.0%-2.9%+17.5%1.6×
Q4 FY2517 May 2025+1.4%+8.6%+10.8%2.7×
Q3 FY2512 Feb 2025-1.5%-4.3%-13.6%0.8×
Q2 FY2514 Nov 2024-6.1%-4.4%+12.9%2.4×
Q1 FY259 Aug 2024-0.9%+6.1%+18.3%0.9×
Q4 FY2415 May 2024-2.9%-1.8%+3.9%3.6×
Q3 FY246 Feb 2024-5.6%-8.2%-8.4%2.9×
Q2 FY248 Nov 2023-4.6%-5.1%-0.4%1.9×
Q1 FY249 Aug 2023-1.6%-5.7%+24.7%1.8×
Q4 FY2328 Apr 2023+2.8%-1.3%+12.6%0.6×
Q3 FY238 Feb 2023-2.3%-3.3%-5.4%1.2×
Q2 FY2315 Nov 2022-6.3%-12.7%-8.3%5.3×
Q1 FY239 Aug 2022-1.8%+7.7%+7.2%1.0×
Q4 FY2230 May 2022-7.2%-12.7%-13.4%3.9×
Q3 FY224 Feb 2022-4.7%-14.1%-29.7%1.7×
Q2 FY2212 Nov 2021-7.4%-14.6%-14.4%6.6×
Q1 FY2213 Aug 2021-7.5%-17.1%-10.1%1.7×
Q4 FY216 Jun 2021-6.1%-6.3%-4.8%2.3×
Q3 FY2110 Feb 2021-4.0%-9.9%-12.9%3.7×
Q2 FY217 Nov 2020-1.9%-2.5%+12.9%1.3×
Q1 FY2131 Jul 2020-3.5%+6.6%-3.1%0.5×
Q4 FY2012 Jun 2020-9.2%-5.9%+86.2%1.5×
Q3 FY2011 Feb 2020+2.9%+24.7%+24.3%5.3×
Q2 FY2015 Nov 2019-2.7%-5.1%-7.5%0.9×
Q1 FY2012 Aug 2019-7.8%-9.3%-10.2%2.2×
Q4 FY1930 May 2019-3.8%-5.3%-7.9%3.9×
Q3 FY1919 Feb 2019+1.9%-3.5%-0.5%0.4×
Q2 FY1927 Nov 2018+9.3%+6.9%+6.4%1.5×
Q1 FY1925 Aug 2018-3.6%-9.0%-3.8%0.7×
Q4 FY1825 May 2018+5.1%-5.4%-7.0%0.4×
Q3 FY1828 Feb 2018-1.9%-9.1%+1.9%0.4×
Q2 FY1821 Nov 2017+5.0%+14.0%+14.7%0.8×
Q1 FY181 Sept 2017+0.8%-2.0%-20.8%1.0×
Q4 FY1715 Jun 2017-0.4%-10.5%+10.9%0.4×
Q3 FY1713 Feb 2017+0.8%+1.6%-2.4%1.9×
Q2 FY177 Nov 2016+0.2%-19.9%-19.3%0.9×
Q1 FY1713 Aug 2016-1.7%+2.6%+10.9%0.2×
Q4 FY164 May 2016+3.1%+9.6%+22.6%1.4×
Q3 FY161 Feb 2016-1.8%+3.9%-2.5%0.6×
Q2 FY162 Nov 2015+0.6%+0.6%+14.2%0.8×
Q1 FY1614 Aug 2015+10.0%+12.3%+10.7%0.5×
Q4 FY1530 May 2015-1.0%-1.6%+48.2%1.9×
Q3 FY1518 Feb 2015-5.3%-10.0%-23.5%0.5×
Q2 FY158 Dec 2014-5.2%-4.1%-11.3%0.1×
Q1 FY1520 Aug 2014-1.6%+0.8%+1.6%1.2×
Q4 FY145 Jun 2014+5.0%+21.5%+6.6%0.1×
Q3 FY1410 Feb 2014+4.8%+20.6%+39.7%0.0×
Q2 FY1412 Nov 2013-1.3%+2.6%+7.8%0.3×
Q1 FY1422 Aug 2013-5.5%-24.2%-9.9%0.0×
Q4 FY1313 Jun 2013+1.5%+17.6%+33.8%0.2×
Q3 FY1318 Feb 20130.0%0.0%+3.1%0.3×
Q2 FY1312 Nov 2012-1.0%-5.0%-6.0%1.4×
Q1 FY1317 Aug 2012-1.1%-5.6%+11.1%0.0×
Q4 FY121 Jun 2012-2.2%-4.3%-3.3%2.6×
Q3 FY1213 Feb 2012+3.8%-2.8%-8.5%0.2×
Q2 FY1221 Nov 2011-3.3%-10.0%-31.7%3.0×
Q1 FY1216 Aug 2011-3.6%-9.4%-11.6%0.3×
Q3 FY118 Feb 2011-5.4%-3.6%-8.4%2.1×
Q2 FY1115 Nov 2010-6.3%-13.0%-22.1%—
Q1 FY114 Nov 2010————
Average-1.3%-2.1%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+37.1%
Profit YoY+89.8%
Interest cost YoY—
Revenue QoQ+22.1%
Profit QoQ+21.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open206.50
Day range204.73 – 216.55
52-week range67.19 – 219.04
From 52w high-1.9%
RSI (14)62.7
ATR (14)11.00
Volume38.89L
Avg volume (20D)40.49L
Rel volume0.96×
Volatility (1Y)50.5%
Turnover₹83.6Cr
SMA 50 / 200182.33 / 120.02

Delivery percentage

Latest · 6 Oct 202638.9%
20-day avg31.4%
1-year avg40.5%
Percentile (own history)46th
Range6.5–100.0%
Sessions1,731

Over the last 20 sessions IOLCP settled 31.4% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 40.5%, so recent sessions are running 9.1 points lower than usual. The latest session ranks higher than 46% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+4.47%+9.48%+9.40%+30.21%+178.04%+106.89%

Valuation

CSV
Market cap₹6,308 Cr
P/E (TTM)37.5
EPS (TTM)5.73
Shares outstanding29.36Cr
Listed8 Nov 2010

Ownership

CSV
Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)567.5580.4619.5756.3
YoY chg——+17.4%+37.1%
Net profit (₹ Cr)30.020.653.264.4
YoY chg——+69.2%+89.8%
Net margin5.3%3.5%8.6%8.5%
EPS1.020.701.812.20

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 62.28% · public 37.72%
30 Sept 2021: promoter 43.69%31 Dec 2021: promoter 43.69%31 Mar 2022: promoter 43.69%30 Jun 2022: promoter 43.69%30 Sept 2022: promoter 43.69%31 Dec 2022: promoter 43.69%31 Mar 2023: promoter 48.19%30 Jun 2023: promoter 48.19%30 Sept 2023: promoter 48.19%31 Dec 2023: promoter 48.19%31 Mar 2024: promoter 48.19%30 Jun 2024: promoter 48.19%30 Sept 2024: promoter 48.19%31 Dec 2024: promoter 52.62%31 Mar 2025: promoter 52.62%30 Jun 2025: promoter 52.62%30 Sept 2025: promoter 52.62%31 Dec 2025: promoter 52.62%31 Mar 2026: promoter 57.48%30 Jun 2026: promoter 62.28%
2021-092026-06
  • Promoter
  • Public and others
Promoter
62.28%
Public
37.72%
Promoter change
+4.80 pp
Filed
4 Jul 2026
FII
4.87%
DII
0.43%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24AQ3 FY24AQ4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue from operations545.3520.4503.9502.4525.8523.3527.8551.7567.5580.4619.5756.3
Other income7.18.47.57.46.44.14.57.46.95.31.88.2
Total income552.4528.8511.4509.8532.2527.4532.3559.1574.4585.7621.3764.4
Total expenses501.2496.7474.2470.2506.2499.6487.6513.6533.9546.9550.5677.8
└ Finance costs4.44.33.42.24.14.54.04.23.53.63.23.6
└ Depreciation15.716.316.416.817.918.718.619.820.020.220.321.3
Profit before tax51.232.137.239.525.927.844.745.540.527.670.886.7
Tax expense13.39.09.69.66.87.313.311.610.57.017.722.3
Net profit37.923.127.630.019.220.531.433.930.020.653.264.4
EPS1.290.790.941.020.650.701.071.161.020.701.812.20
Net margin6.94%4.44%5.48%5.97%3.64%3.92%5.95%6.15%5.28%3.55%8.58%8.52%
PBT margin9.39%6.17%7.38%7.87%4.93%5.31%8.47%8.25%7.13%4.75%11.43%11.46%
Tax rate26.01%28.08%25.75%24.16%26.18%26.15%29.71%25.44%25.98%25.30%24.93%25.71%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 10 Aug 2026.

IOLCP at a glance

  • IOLCP closed at ₹214.9 on 6 Oct 2026, +4.47% on the day, +106.9% over one year, 1.9% below its 52-week high of ₹219.04.
  • Delivery was 38.9% of traded quantity on 6 Oct 2026, the 46th percentile of its own 1,731 sessions with a reading (20-session average 31.4%, 1-year average 40.5%).
  • Market capitalisation is ₹6,308 crore at a trailing P/E of 37.5 (trailing EPS ₹5.73).
  • Q1 FY27 results (consolidated, filed 10 Aug 2026): revenue ₹756 crore (+37.1% year on year), net profit ₹64 crore (+89.8%); the price moved -1.9% on the first session after.
  • Promoters held 62.28% at 30 Jun 2026, up 4.80 percentage points on the previous filing.
  • Q2 FY27 results are expected between 8 Nov 2026 and 15 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE485C01029
SeriesEQ
Listed8 Nov 2010
History from8 Nov 2010
Sessions3,816
Turnover rank#348

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE